TipRanks
Xeris Pharmaceuticals (DE:2B30)
FRANKFURT:2B30
Germany Market
2B30
Xeris Pharmaceuticals
RESEARCH TOOLSreports

Xeris Pharmaceuticals (2B30) Balance Sheet

0 Followers

Xeris Pharmaceuticals Balance Sheet

Xeris Pharmaceuticals's total assets for Q2 2026 were $411.90M, an increase of 5.07% from the previous quarter. DE:2B30 total liabilities were $421.64M for the fiscal quarter, a 11.25% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Assets
$ 383.53M$ 323.06M$ 322.60M$ 344.52M$ 304.36M
Total Liabilities
$ 369.84M$ 352.68M$ 329.38M$ 299.33M$ 209.13M
Total Equity Gross Minority
$ 13.69M$ -29.61M$ -6.78M$ 45.19M$ 95.23M
Other Metrics
Currency in USD

Xeris Pharmaceuticals Debt to Assets